Inactive Instrument

News Occlutech Holding AG

Equities

Occlutech Holding AG Continues its Progress in US FDA Study OCCLUFLEX – Enrolls First Patient in Europe	31/01/23	CI
Occlutech Holding AG Appoints Jozef Bartunek as New Chief Medical Officer	01/11/22	CI
Occlutech Holding AG Appoints Jose De La Cortina as Chief Commercial Officer	06/09/22	CI
Occlutech Holding AG announced that it has received SEK 450 million in funding from AP Fonden 4, Carnegie Investment Bank AB	20/12/21	CI
Occlutech Holding AG has withdrawn its IPO in the amount of SEK 963.8035 million.	28/09/21	CI
Occlutech Holding AG has filed an IPO in the amount of SEK 963.8035 million.	08/09/21	CI
Occlutech Holding AG announced that it has received funding from COI Partners	30/12/12	CI

No results for this search